Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-09-13 Purchase |
2024-09-17 9:00 pm |
Viridian Therapeutics Inc. | VRDN | Fairmount Funds Management LLC Fairmount Healthcare Fund II GP LLC Fairmount Healthcare Fund II L.P. Director 10% Owner |
1,600,000 | $18.75 | $30,000,000 | 3,445,813 (Indirect) |
View |
| 2024-09-16 Purchase(A) |
2024-09-17 8:56 pm |
Zenas BioPharma Inc. | ZBIO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director |
300,000 | $17 | $5,100,000 | 1,929,806 (Indirect) |
View |
| 2024-09-16 Purchase |
2024-09-16 8:54 pm |
Zenas BioPharma Inc. | ZBIO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director |
300,000 | $17 | $5,100,000 | 1,641,891 (Indirect) |
View |
| 2024-01-22 Purchase |
2024-01-24 6:44 pm |
Viridian Therapeutics Inc. | VRDN | Fairmount Funds Management LLC Fairmount Healthcare Fund GP LLC Fairmount Healthcare Fund II GP LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. See Remarks 10% Owner |
476,190 | $21 | $9,999,990 | 1,845,813 (Indirect) |
View |
| 2023-07-13 Purchase |
2023-07-17 8:00 pm |
Apogee Therapeutics Inc. | APGE | Fairmount Funds Management LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest II L.P. Kiselak Tomas Harwin Peter Evan Director |
2,941,176 | $17 | $49,999,992 | 988,045 (Indirect Direct) |
View |
| 2022-08-17 Purchase |
2022-08-19 4:32 pm |
Viridian Therapeutics Inc. | VRDN | Fairmount Funds Management LLC Fairmount Healthcare Fund GP LLC Fairmount Healthcare Fund II GP LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. See Remarks 10% Owner |
425,531 | $23.5 | $9,999,979 | 1,369,623 (Indirect) |
View |
| 2021-09-21 Purchase |
2021-09-23 09:30 am |
Viridian Therapeutics Inc. | VRDN | Fairmount Funds Management LLC Fairmount Healthcare Fund GP LLC Fairmount Healthcare Fund II GP LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Director 10% Owner |
909,000 | $11 | $9,999,000 | 1,077,283 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-11-19 Exercise |
2024-11-21 6:30 pm |
N/A N/A |
Oruka Therapeutics Inc. | ORKA | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner |
160,160 | $0 | 3,371,922 (Indirect) |
View |
| 2024-09-16 Conversion(A) |
2024-09-17 8:56 pm |
N/A N/A |
Zenas BioPharma Inc. | ZBIO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director |
12,635,428 | $0 | 1,929,806 (Indirect) |
View |
| 2024-09-12 Option Award(A) |
2024-09-17 8:56 pm |
N/A 2034-09-11 |
Zenas BioPharma Inc. | ZBIO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director |
37,000 | $0 | 1,929,806 (Indirect) |
View |
| 2024-09-16 Conversion |
2024-09-16 8:54 pm |
N/A N/A |
Zenas BioPharma Inc. | ZBIO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director |
12,635,428 | $0 | 1,641,891 (Indirect) |
View |
| 2024-09-12 Option Award |
2024-09-16 8:54 pm |
N/A 2034-09-11 |
Zenas BioPharma Inc. | ZBIO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director |
37,000 | $0 | 1,641,891 (Indirect) |
View |
| 2024-09-11 Option Award |
2024-09-13 4:55 pm |
N/A N/A |
Oruka Therapeutics Inc. | ORKA | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner |
275,000 | $23 | 3,212,082 (Indirect) |
View |
| 2024-09-11 Option Award |
2024-09-13 4:55 pm |
N/A N/A |
Oruka Therapeutics Inc. | ORKA | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner |
160 | $23,000 | 3,212,082 (Indirect) |
View |
Ownership |
2024-09-12 9:41 pm |
N/A N/A |
Zenas BioPharma Inc. | ZBIO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner |
0 | $0 | 1,592,806 (Indirect) |
View |
Ownership |
2024-09-06 5:07 pm |
N/A N/A |
Oruka Therapeutics Inc. | ORKA | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest III L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner |
0 | $0 | 19,662,752 (Indirect) |
View |
| 2024-04-25 Exercise |
2024-04-25 4:55 pm |
N/A N/A |
Spyre Therapeutics Inc. | SYRE | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director |
3,730,672 | $0 | 5,176,222 (Indirect) |
View |
| 2024-03-28 Other |
2024-04-01 6:32 pm |
N/A N/A |
Viridian Therapeutics Inc. | VRDN | Fairmount Funds Management LLC Fairmount Healthcare Fund GP LLC Fairmount Healthcare Fund II GP LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Director 10% Owner |
49,857 | $0 | 1,990,722 (Indirect) |
View |
| 2024-03-28 Other |
2024-04-01 5:44 pm |
N/A N/A |
Apogee Therapeutics Inc. | APGE | Fairmount Funds Management LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director |
498,765 | $0 | 9,006,126 (Indirect) |
View |
| 2024-01-29 Other |
2024-01-31 4:31 pm |
N/A N/A |
Apogee Therapeutics Inc. | APGE | Fairmount Funds Management LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest II L.P. Kiselak Tomas Harwin Peter Evan Director |
943,695 | $0 | 1,046,027 (Indirect) |
View |
| 2023-12-29 Other |
2023-12-29 5:00 pm |
N/A N/A |
Spyre Therapeutics Inc. | SYRE | Fairmount Funds Management LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner |
3,841,518 | $0 | 5,485,719 (Indirect) |
View |
| 2023-12-07 Option Award |
2023-12-11 5:41 pm |
N/A N/A |
Spyre Therapeutics Inc. | SYRE | Fairmount Funds Management LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner |
16,667 | $600 | 16,667 (Indirect) |
View |
| 2023-11-24 Conversion |
2023-11-28 4:05 pm |
N/A N/A |
Spyre Therapeutics Inc. | AGLE | Fairmount Funds Management LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner |
3,521,367 | $0 | 4,250,938 (Indirect) |
View |
| 2023-10-30 Option Award |
2023-11-01 9:05 pm |
N/A N/A |
Viridian Therapeutics Inc. | VRDN | Fairmount Funds Management LLC Fairmount Healthcare Fund GP LLC Fairmount Healthcare Fund II GP LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. See Remarks 10% Owner |
48,463 | $825.37 | 48,463 (Indirect) |
View |
| 2023-07-13 Option Award |
2023-07-17 8:00 pm |
N/A 2033-07-13 |
Apogee Therapeutics Inc. | APGE | Fairmount Funds Management LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest II L.P. Kiselak Tomas Harwin Peter Evan Director |
95,516 | $0 | 988,045 (Direct) |
View |
Ownership |
2023-07-13 6:39 pm |
N/A N/A |
Apogee Therapeutics Inc. | APGE | Fairmount Funds Management LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Director |
0 | $0 | 6,743,321 (Indirect) |
View |
Ownership |
2023-06-30 5:32 pm |
N/A N/A |
Aeglea BioTherapeutics Inc. | AGLE | Fairmount Funds Management LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner |
0 | $0 | 536,284,540 (Indirect) |
View |
Ownership |
2020-10-30 11:43 am |
N/A N/A |
MIRAGEN THERAPEUTICS INC. | MGEN | Fairmount Funds Management LLC Fairmount Healthcare Fund GP LLC Fairmount Healthcare Fund II GP LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. See Remarks |
0 | $0 | 131,717,393 (Indirect) |
View |
| 2020-10-27 Other |
2020-10-29 11:30 am |
N/A N/A |
MIRAGEN THERAPEUTICS INC. | MGEN | Fairmount Funds Management LLC Fairmount Healthcare Fund GP LLC Fairmount Healthcare Fund II GP LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. See Remarks |
625,247 | $0 | 1,063,749 (Indirect) |
View |